Your browser doesn't support javascript.
loading
Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.
Miglis, Mitchell G; Adler, Charles H; Antelmi, Elena; Arnaldi, Dario; Baldelli, Luca; Boeve, Bradley F; Cesari, Matteo; Dall'Antonia, Irene; Diederich, Nico J; Doppler, Kathrin; Dusek, Petr; Ferri, Raffaele; Gagnon, Jean-François; Gan-Or, Ziv; Hermann, Wiebke; Högl, Birgit; Hu, Michele T; Iranzo, Alex; Janzen, Annette; Kuzkina, Anastasia; Lee, Jee-Young; Leenders, Klaus L; Lewis, Simon J G; Liguori, Claudio; Liu, Jun; Lo, Christine; Ehgoetz Martens, Kaylena A; Nepozitek, Jiri; Plazzi, Giuseppe; Provini, Federica; Puligheddu, Monica; Rolinski, Michal; Rusz, Jan; Stefani, Ambra; Summers, Rebekah L S; Yoo, Dallah; Zitser, Jennifer; Oertel, Wolfgang H.
Affiliation
  • Miglis MG; Department of Neurology and Neurological Sciences and Department of Psychiatry and Behavioral Science, Stanford University, Palo Alto, CA, USA. Electronic address: mmiglis@stanford.edu.
  • Adler CH; Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, AZ, USA.
  • Antelmi E; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Arnaldi D; Clinical Neurology, DINOGMI, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Baldelli L; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
  • Boeve BF; Department of Neurology and Center for Sleep Medicine, Mayo Clinic, Rochester, MN, USA.
  • Cesari M; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Dall'Antonia I; Department of Neurology and Center of Clinical Neuroscience, Charles University First Faculty of Medicine, Prague, Czech Republic.
  • Diederich NJ; Department of Neuroscience, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.
  • Doppler K; Department of Neurology, University of Würzburg, Würzburg, Germany.
  • Dusek P; Department of Neurology and Center of Clinical Neuroscience, Charles University First Faculty of Medicine, Prague, Czech Republic.
  • Ferri R; Oasi Research Institute IRCCS, Troina, Italy.
  • Gagnon JF; Centre for Advanced Research in Sleep Medicine, Centre intégré universitaire de santé et de services sociaux du Nord-de-l'Île-de-Montréal-Hôpital du Sacré-Coeur de Montréal, Montreal, QC, Canada.
  • Gan-Or Z; The Neuro-Montreal Neurological Institute-Hospital, Department of Neurology and Neurosurgery, and Department of Human Genetics, McGill University, Montreal, QC, Canada.
  • Hermann W; Department of Neurology, University of Rostock, Rostock, Germany; German Center for Neurodegenerative Diseases (DZNE), Research Site Rostock, Rostock, Germany.
  • Högl B; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Hu MT; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Iranzo A; Sleep Disorders Center, Neurology Service, Hospital Clínic Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Janzen A; Department of Neurology and Section on Clinical Neuroscience, Philipps University Marburg, Marburg, Germany.
  • Kuzkina A; Department of Neurology, University of Würzburg, Würzburg, Germany.
  • Lee JY; Department of Neurology, Seoul National University College of Medicine, Seoul, South Korea.
  • Leenders KL; Department of Nuclear Medicine and Biomedical Imaging, University Medical Center Groningen, Groningen, Netherlands.
  • Lewis SJG; ForeFront Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.
  • Liguori C; Sleep Medicine Center, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Liu J; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Lo C; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Ehgoetz Martens KA; Department of Kinesiology, Faculty of Applied Health Sciences, University of Waterloo, Waterloo, ON, Canada.
  • Nepozitek J; Department of Neurology and Center of Clinical Neuroscience, Charles University First Faculty of Medicine, Prague, Czech Republic.
  • Plazzi G; IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Provini F; Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; UOC Clinica Neurologica Rete Metropolitana NEUROMET, Bellaria Hospital, Bologna, Italy.
  • Puligheddu M; Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
  • Rolinski M; Institute of Clinical Neurosciences, University of Bristol, Bristol, UK.
  • Rusz J; Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
  • Stefani A; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
  • Summers RLS; Department of Neurology, University of Minnesota, Minneapolis, MN, USA.
  • Yoo D; Department of Neurology, Kyung Hee University Hospital, Seoul, South Korea.
  • Zitser J; Department of Neurology and Neurological Sciences, University of California, San Francisco, CA, USA; Department of Neurology, Tel Aviv Sourasky Medical Center, Affiliate of Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Oertel WH; Department of Neurology and Section on Clinical Neuroscience, Philipps University Marburg, Marburg, Germany; Institute for Neurogenomics, Helmholtz Center for Health and Environment, München-Neuherberg, Germany.
Lancet Neurol ; 20(8): 671-684, 2021 08.
Article de En | MEDLINE | ID: mdl-34302789
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques / Trouble du comportement en sommeil paradoxal / Synucléinopathies Type d'étude: Etiology_studies / Prognostic_studies Limites: Humans Langue: En Journal: Lancet Neurol Sujet du journal: NEUROLOGIA Année: 2021 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques / Trouble du comportement en sommeil paradoxal / Synucléinopathies Type d'étude: Etiology_studies / Prognostic_studies Limites: Humans Langue: En Journal: Lancet Neurol Sujet du journal: NEUROLOGIA Année: 2021 Type de document: Article